![Robert Cuthbertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Cuthbertson
Directeur/Membre du Conseil chez
ZENYTH THERAPEUTICS LIMITED
Fortune : 6 M $ au 30/06/2026
Profil
Robert Andrew Cuthbertson is currently Director at CSL Innovation Pty Ltd., Non-independent Executive Director at CSL Behring LLC since 2018, Director at Centre for Eye Research Australia since 2017, Director at Grattan Institute since 2019, Non-Executive Director at CSL Ltd. since 2021, and Deputy Chancellor at the University of Melbourne since 2023.
Formerly, Dr. Cuthbertson was Senior Scientist at Genentech, Inc. from 1992 to 1997, and a Member at both the National Institutes of Health and the Howard Florey Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED 0,01 % | 17/02/2026 | 71 128 ( 0,01 % ) | 6 M $ | 30/06/2026 |
Postes actifs de Robert Cuthbertson
| Sociétés | Poste | Début |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Directeur/Membre du Conseil | - |
| CSL LIMITED | Directeur/Membre du Conseil | 17/10/2018 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Directeur/Membre du Conseil | 01/01/2018 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2016 |
Centre for Eye Research Australia
 Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Directeur/Membre du Conseil | 01/03/2017 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Directeur/Membre du Conseil | 01/01/2019 |
Anciens postes connus de Robert Cuthbertson
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/1997 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Centre for Eye Research Australia
Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Commercial Services |
